Location: Home
  • search
  • go
  • Relate News
  • 12/16/2019NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
  • 12/16/2019BeiGene's Brukinsa Fails to Match AbbVie-J&J Rival Imbruvica in La...
  • 12/16/2019A Few Details on the US-China "Phase One" Trade Deal
  • 12/16/2019The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusion...
  • 12/13/2019Recent Executive Moves
  • 12/13/2019BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Combo wit...
  • 12/13/2019ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Trial o...
  • 12/13/2019Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
  • 12/13/2019IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
  • 12/12/2019Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...
  • 12/12/2019Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...
  • 12/12/2019Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...
  • 12/12/2019AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...
  • 12/11/2019Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...
  • 12/11/2019Harbin Pharmaceutical Group Poised to Take Over Ailing GNC
  • 12/10/2019National Drug Usage Monitoring Platform Becomes Operational
  • 12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...
  • 12/10/2019China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...
  • 12/9/2019PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...
  • 12/9/2019Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...
  • 12/6/2019NHSA Issues New Policy for Drug Price Regulation
  • 12/6/2019Recent Executive Moves
  • 12/6/2019Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...
  • 12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China
  • 12/5/2019XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...
  • 12/5/2019AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer
  • 12/4/2019Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...
  • 12/4/2019Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...
  • 12/3/2019Why Chinese Biotech Companies Are Not For Faint-Hearted Investors
  • 12/3/2019New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...
  • Page:103/334 Total number of articles:9993: [First][<<] [101] [102] [103] [104] [105] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group